Dataset Information

Improved Performance of Positive-ion mode Free Radical-Initiated Peptide Sequencing with p-TEMPO-Bz

ABSTRACT: Free radical-initiated peptide sequencing (FRIPS) is a tandem mass spectrometry (MS/MS) technique that generates sequence informative ions via collisionally-initiated radical chemistry. Collision activation (CA) homolytically cleaves an installed radical precursor, initiates radical formation, extensive hydrogen atom transfer, and peptide backbone dissociation. While FRIPS technique shows great promise, when applied to multiply charged derivatized peptide ions, a series of high abundance mass losses are observed which syphon ion abundance from radically generated sequence ions. This loss of ion abundance reduces the sequence coverage generated by FRIPS fragmentation. In this work, we hypothesized that these mass losses were instigated by the ortho-orientation of the radical precursor undergoing facile conversion into five- or six-membered intermediates and that the para-precursor would not undergo this chemistry. To test this assertion, we synthesized para-TEMPO-Bz, conjugated it to these peptides, and collisionally activated each. And indeed, we see the complete elimination of these undesired collisional processes and the significant increase in radical precursor ion abundance. The increase in ion abundance leads to a significant increase in the sequence coverage generated. These results demonstrate that p-TEMPO-Bz significantly improves the performance of positive-ion mode FRIPS and may be a suitable alternative to the currently utilized ortho-TEMPO-Bz-based FRIPS.

INSTRUMENT(S): Orbitrap Fusion

ORGANISM(S): Standards

SUBMITTER: Nicholas Borotto

PROVIDER: MSV000091064 | MassIVE | Fri Jan 13 16:14:00 GMT 2023

REPOSITORIES: MassIVE

ACCESS DATA

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Project description:Data independent acquisition-mass spectrometry (DIA-MS) coupled with liquid chromatography is a promising approach for rapid, automatic sampling of MS/MS data in untargeted metabolomics. However, wide isolation windows in DIA-MS generate MS/MS spectra containing a mixed population of fragment ions together with their precursor ions. This precursor-fragment ion map in a comprehensive MS/MS spectral library is crucial for relative quantification of fragment ions uniquely representative of each precursor ion. However, existing reference libraries are not sufficient for this purpose since the fragmentation patterns of small molecules can vary in different instrument setups. Here we developed a bioinformatics workflow called MetaboDIA to build customized MS/MS spectral libraries using a user's own data dependent acquisition (DDA) data and to perform MS/MS-based quantification with DIA data, thus complementing conventional MS1-based quantification. MetaboDIA also allows users to build a spectral library directly from DIA data in studies of a large sample size. Using a marine algae data set, we show that quantification of fragment ions extracted with a customized MS/MS library can provide as reliable quantitative data as the direct quantification of precursor ions based on MS1 data. To test its applicability in complex samples, we applied MetaboDIA to a clinical serum metabolomics data set, where we built a DDA-based spectral library containing consensus spectra for 1829 compounds. We performed fragment ion quantification using DIA data using this library, yielding sensitive differential expression analysis. </br></br> Serum metabolome of 40 age-related macular degeneration patients and 20 control samples was analyzed using untargeted mass spectrometry. We used data dependent acquisition data to build a MS/MS spectral assay library for more than 1,000 compounds and performed targeted extraction of MS2 ion chromatograms from data independent acquisition analysis.

Project description:Top down identification of proteins detected by MALDI imaging. Childhood absence epilepsy is a prototypic form of generalized nonconvulsive epilepsy characterized by short impairments of consciousness concomitant with synchronous and bilateral spike-and-wave discharges in the electroencephalogram. For scientists in this field, the BS/Orl and BR/Orl mouse lines, derived from a genetic selection, constitute an original mouse model "in mirror" of absence epilepsy. The potential of MALDI imaging mass spectrometry (IMS) for the discovery of potential biomarkers is increasingly recognized. Interestingly, statistical analysis tools specifically adapted to IMS data sets and methods for the identification of detected proteins play an essential role. In this study, a new cross-classification comparative design using a combined discrete wavelet transformation-support vector machine classification was developed to discriminate spectra of brain sections of BS/Orl and BR/Orl mice. Nineteen m/z ratios were thus highlighted as potential markers with very high recognition rates (87-99%). Seven of these potential markers were identified using a top-down approach, in particular a fragment of Synapsin-I. This protein is yet suspected to be involved in epilepsy. Immunohistochemistry and Western Blot experiments confirmed the differential expression of Synapsin-I observed by IMS, thus tending to validate our approach. Functional assays are being performed to confirm the involvement of Synapsin-I in the mechanisms underlying childhood absence epilepsy. Data processing and bioinformatics: The ProSight PC 2.0 software(Thermo Scientific) was used to create the peak list from .raw data. RAW files were processed using the Xtract algorithm that interprets resolved isotopic distributions and output neutral mass values. In this study, two search modes were used: “absolute mass” search for the identification of full-length proteins and “biomarker” search for the identification of protein fragments. For absolute mass search, ProSight PC restricts the protein database to proteins matching the mass of the precursor, whereas for biomarker search, the protein database is restricted to each protein subsequence matching the mass of the precursor. In order to determine the false discovery rate (FDR), the FASTA format Uniprot database (release 2011_08, 531473 sequences, 188463640 residues) filtered with the Mus musculus taxonomy (16401 sequences) was concatenated with a decoy database constituted by randomized protein sequences. The resulting database was imported in the ProSight PC 2.0 software and configured for top-down analysis. For each analyzed fraction, the FDR was calculated as follows: FDR = 2 × FP/(FP + TP), where FP and TP are the number of matches from the decoy and target database, respectively. All identifications reported here correspond to a FDR lower than 5%. MS/MS spectra were searched against the database using the absolute mass search mode with a precursor ion mass tolerance of 10 ppm and a fragment ion mass tolerance of 15 ppm on monoisotopic masses. The identification score is based on the number of observed fragment ions matching the fragment ion tolerance. A second absolute mass search was performed with a loose precursor ion tolerance of 1000 Da to evidence post-translational modifications. The Sequence Gazer tool was used to manually check proteins identified with a significant score but with a difference between the theoretical precursor ion mass and the observed precursor ion mass. Post-translational modification(s) can thus be localized on the sequence of the protein due to mass shift(s) observed for b and/or y ions. MS/MS spectra were then searched using the biomarker search mode with a precursor ion mass tolerance of 10 ppm and a fragment ion mass tolerance of 15 ppm on monoisotopic masses to identify fragments of intact proteins present in the database. A new database was then constructed from all protein sequences identified with the previous searches in order to perform a biomarker search with a precursor ion mass tolerance of 100 Da and a fragment ion mass tolerance of 15 ppm. Indeed, such precursor ion mass tolerance in the biomarker search mode is unusable for large databases such as the Uniprot database filtered with the Mus musculus taxonomy (16401 sequences) and requires the use of small databases. This search was performed to identify modified fragments of previously identified proteins that could not have been identified with the biomarker search performed with a precursor ion mass tolerance of 10 ppm. The Sequence Gazer tool was used to manually localize post-translational modification(s) on the sequence of the protein fragments due to mass shift(s) observed for b and/or y ions.

Project description:Human deep space and planetary travel is limited by uncertainties regarding the health risks associated with exposure to galactic cosmic radiation (GCR), and in particular the high linear energy transfer (LET), heavy ion component. Here we assessed the impact of two high-LET ions 56Fe and 28Si, and low-LET X rays on genome-wide methylation patterns in human bronchial epithelial cells. We found that all three radiation types induced rapid and stable changes in DNA methylation but at distinct subsets of CpG sites affecting different chromatin compartments. The 56Fe ions induced mostly hypermethylation, and primarily affected sites in open chromatin regions including enhancers, promoters and edges (“shores”) of CpG islands. The 28Si ion-exposure had mixed effects, inducing both hyper and hypomethylation and affecting sites in more repressed heterochromatic environments, whereas X rays induced mostly hypomethylation, primarily at sites in gene bodies and intergenic regions. Significantly, the methylation status of 56Fe ion irradiation sensitive sites, but not those affected by X ray or 28Si ions, could discriminate tumor from normal tissue for human lung adenocarcinomas and squamous cell carcinomas. Thus, high LET radiation exposure leaves a lasting imprint on the epigenome, and affects sites relevant to human lung cancer. The 56Fe ion signature may prove useful in monitoring the cumulative biological impact and associated cancer risks encountered by astronauts in deep space. Genome wide DNA methylation profiling of normal human bronchial epithelial cells irradiated with varying doses of 28Si-ion radiation ( 300 MeV/u at 0, 0.3, 1.0 Gy) , 56Fe-ion radiation (600 MeV/u at 0, 0.1, 0.3, 1.0 Gy) or X rays (320 kV at 0, 1.0 Gy). Triplicate control and irradiated samples were incubated and sampled at 4 timepoints between 2 and 62 days. The Illumina Infinium 450k Human DNA methylation Beadchip was used to obtain DNA methylation profiles across >485,000 CpGs from collected samples. Samples include: 56Fe ions, 4 doses x 4 time points x 3 replicates (4 removed in QC) = 44 samples; 28Si ions = 3 doses x 4 time points x 3 replicates = 36 samples; X ray, 2 doses x 4 time points x 3 replicates (2 removed in QC)= 22 samples.

Dataset Information

Improved Performance of Positive-ion mode Free Radical-Initiated Peptide Sequencing with p-TEMPO-Bz

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets